Stefan Schneider
Prof. Dr. med.
Stefan W Schneider
  • Klinikdirektor
  • Facharzt für Haut- und Geschlechtskrankheiten
Arbeitsbereich

Kontakt

Standort

W14, EG
Sprachen
Deutsch (Muttersprache)
Englisch

Fachgebiete

Tätigkeitsschwerpunkte

Publikationen

Zurück
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2007
  • 2006
Vor

Patient-reported outcomes of topical finasteride/minoxidil treatment for male androgenetic alopecia: A retrospective study using telemedical data
Abeck F, Hansen I, Kött J, Schröder F, Garrahy E, Veneroso J, Rünger A, Torster L, Schneider S, von Büren J
J COSMET DERMATOL-US. 2024;23(9):2956-2963.

Effects of a skin type diversity seminar on undergraduate medical students' self-assessed competence in managing skin diseases in patients with skin of color
Abeck F, Heinen I, Sommer R, Blome C, Härter M, Augustin M, Schneider S, Hansen-Abeck I, Booken N
BMC MED EDUC. 2024;24(1):848.

Differential predictive value of tissue-specific PD-L1 expression scores in adjuvant immunotherapy of melanoma
Geidel G, Parnian N, Meß C, Schlepper N, Rünger A, Heidrich I, Hansen I, Smit D, Menz A, Pantel K, Schneider S, Kött J, Gebhardt C
J EUR ACAD DERMATOL. 2024;38(10):2017-2023.

Pegylated interferon-α2a in cutaneous T-cell lymphoma - a multicenter retrospective data analysis with 70 patients
Hansen-Abeck I, Geidel G, Abeck F, Kött J, Cankaya R, Dobos G, Mitteldorf C, Nicolay J, Albrecht J, Menzer C, Livingstone E, Mengoni M, Braun A, Wobser M, Klemke C, Tratzmiller S, Assaf C, Terheyden P, Klespe K, Schneider S, Booken N
J DTSCH DERMATOL GES. 2024 [Epub ahead of print].

Erfolgreiche Behandlung eines Checkpoint‐Inhibitor‐assoziierten bullösen Pemphigoids mit Dupilumab bei Angiosarkom
Hansen I, Gebhardt C, Booken N, Schneider S
J DTSCH DERMATOL GES. 2024;22(4):587-590.

Successful treatment of checkpoint inhibitor-associated bullous pemphigoid with dupilumab in a patient with angiosarcoma
Hansen I, Gebhardt C, Booken N, Schneider S
J DTSCH DERMATOL GES. 2024;22(4):587-589.

Successful treatment of refractory checkpoint inhibitor-induced hepatitis with quadruple therapy including extracorporeal photopheresis and infliximab
Hansen I, Kött J, Heidenreich S, Ayuk F, Doll P, Abeck F, Booken N, Gebhardt C, Schneider S
Journal of the European Academy of Dermatology and Venerology Clinical Practice. 2024;3(1):317-320.

High Serum Levels of CCL20 Are Associated with Recurrence and Unfavorable Overall Survival in Advanced Melanoma Patients Receiving Immunotherapy
Kött J, Hoehne I, Heidrich I, Zimmermann N, Reese K, Zell T, Geidel G, Rünger A, Schneider S, Pantel K, Smit D, Gebhardt C
CANCERS. 2024;16(9):.

C-reactive protein flare predicts response to checkpoint inhibitor treatment in melanoma
Kött J, Zimmermann N, Zell T, Heidrich I, Geidel G, Rünger A, Smit D, Merkle M, Parnian N, Hansen I, Hoehne I, Abeck F, Torster L, Weichenthal M, Pantel K, Schneider S, Gebhardt C
J EUR ACAD DERMATOL. 2024;38(8):1575–1587.

Rosacea treatment with 532 nm KTP versus 595 nm pulsed dye laser-A prospective, controlled study
Nguyen L, Dierckxsens C, Kerscher M, Hartjen A, Schneider S, Herberger K
J COSMET DERMATOL-US. 2024;23(7):2443-2449.

Unmasking inadequate healthcare: Laser hair removal for transfemme adults in Germany
Nguyen L, Heilberger J, Kampmann A, Schneider S, Nieder T, Herberger K
INT J TRANSGEND HEAL. 2024 [Epub ahead of print];2024:1-9.

Mutation analysis in individual circulating tumor cells depicts intratumor heterogeneity in melanoma
Sementsov M, Ott L, Kött J, Sartori A, Lusque A, Degenhardt S, Segier B, Heidrich I, Volkmer B, Greinert R, Mohr P, Simon R, Stadler J, Irwin D, Koch C, Andreas A, Deitert B, Thewes V, Trumpp A, Schneeweiss A, Belloum Y, Peine S, Wikman H, Riethdorf S, Schneider S, Gebhardt C, Pantel K, Keller L
EMBO MOL MED. 2024;16(7):1560-1578.

A Rejected Hypothesis: Phenomenon of High Treatment Adherence in Direct-to-Consumer Teledermatology Despite Lack of Direct Physician-Patient Interaction
Abeck F, Hansen I, Wiesenhütter I, Brookman-May S, Sharaf K, Kött J, Bertlich M, Schneider S, von Büren J
TELEMED E-HEALTH. 2023;29(7):1051-1056.

Online Traffic Analysis of Direct-to-Consumer Websites for Hair Loss Treatment and Characterization of Finasteride Patients on a Platform in Germany: A Potential Paradigm Shift in the Treatment of Androgenetic Alopecia
Abeck F, Hansen I, Wiesenhütter I, Schröder F, Kött J, Schneider S, von Büren J
CLIN COSMET INV DERM. 2023;16:937-945.

Direct-to-Consumer Teledermatology in Germany: A Retrospective Analysis of 1,999 Teleconsultations Suggests Positive Impact on Patient Care
Abeck F, Kött J, Bertlich M, Wiesenhütter I, Schröder F, Hansen I, Schneider S, von Büren J
TELEMED E-HEALTH. 2023;29(10):1484-1491.

A case of COVID-19-associated generalized indeterminate cell histiocytosis successfully treated with systemic PUVA
Abeck F, Vehring J, Varwig-Janßen D, Menz A, Christolouka M, Schneider S
J EUR ACAD DERMATOL. 2023;37(12):e1372-e1374.

Germ Cell Maintenance and Sustained Testosterone and Precursor Hormone Production in Human Prepubertal Testis Organ Culture with Tissues from Boys 7 Years+ under Conditions from Adult Testicular Tissue
Aden N, Bleeke M, Kordes U, Brunne B, Holstermann B, Biemann R, Ceglarek U, Soave A, Salzbrunn A, Schneider S, Kopylow K
CELLS-BASEL. 2023;12(3):.

Schnelle Abheilung einer schweren Psoriasis vulgaris bei einem HIV-positiven Patienten unter antiretroviraler Therapie
Bauditz L, Booken N, Schneider S, Abeck F
DERMATOLOGIE. 2023;74(4):282-285.

The potential of telemedicine for dermatological care of pediatric patients in Germany
Hansen I, Abeck D, Kött J, Schneider S, Abeck F
J DTSCH DERMATOL GES. 2023;21(2):141-145.

Asymptomatic erythematous plaque on the lower leg
Hansen I, Abeck F, Heidrich I, Schneider S, Booken N
J DTSCH DERMATOL GES. 2023;21(7):813-815.

Asymptomatische erythematöse Plaque am Unterschenkel
Hansen I, Abeck F, Heidrich I, Schneider S, Booken N
J DTSCH DERMATOL GES. 2023;21(7):813-815.

Therapie des nekrobiotischen Xanthogranuloms - Fallserie und aktuelle Literatur:
Hansen I, Ghandili S, Abeck F, Booken N, Schneider S
J DTSCH DERMATOL GES. 2023;21(11):1315-1319.

Therapy of necrobiotic xanthogranuloma - case series and review of the literature
Hansen I, Ghandili S, Abeck F, Booken N, Schneider S
J DTSCH DERMATOL GES. 2023;21(11):1315-1318.

Letaler Verlauf einer Kryoglobulinämie Typ I
Hansen I, Ghandili S, Abeck F, Kött J, Booken N, Schneider S
J DTSCH DERMATOL GES. 2023;21(Suppl 2):15-18.

Successful Treatment of PD-1 Inhibitor-induced Psoriasis with Infliximab
Hansen I, Heidrich I, Abeck F, Kött J, Booken N, Gebhardt C, Schneider S
J EUR ACAD DERMATOL. 2023;37(5):e621-e623.

Von Willebrand factor in the plasma and in the tumor tissue predicts cancer-associated thrombosis and mortality
Karampinis I, Nowak K, Koett J, Mess C, Wagner L, Gaiser T, Mayer F, Goertz L, Schneider S, Bauer A
HAEMATOLOGICA. 2023;108(1):261-266.

Active remodeling of capillary endothelium via cancer cell-derived MMP9 promotes metastatic brain colonization
Karreman M, Bauer A, Solecki G, Berghoff A, Mayer C, Frey K, Hebach N, Feinauer M, Schieber N, Tehranian C, Mercier L, Singhal M, Venkataramani V, Schubert M, Hinze D, Hölzel M, Helfrich I, Schadendorf D, Schneider S, Westphal D, Augustin H, Goetz J, Schwab Y, Wick W, Winkler F
CANCER RES. 2023;83(8):1299-1314.

Behandlung von Feuermalen mit dem gepulsten Farbstofflaser - Analyse der Versorgungssituation in Deutschland
Nguyen L, Kleeberg A, Seeber N, Kimmig W, Schneider S, Herberger K
J DTSCH DERMATOL GES. 2023;21(10):1218-1220.

Pulsed dye laser treatment of port-wine stains - Analysis of health service in Germany
Nguyen L, Kleeberg A, Seeber N, Kimmig W, Schneider S, Herberger K
J DTSCH DERMATOL GES. 2023;21(10):1218-1220.

In vivo characterization of laser-assisted delivery of hyaluronic acid using multiphoton fluorescence lifetime imaging
Nguyen L, Mess C, Schneider S, Huck V, Herberger K
EXP DERMATOL. 2023;32(12):2131-2137.

Pikosekundenlaser in der Dermatologie
Nguyen L, Schneider S, Herberger K
DERMATOLOGIE. 2023;74(6):440-447.

Thermal eye injuries from dermatologic laser treatments-an experimental study
Nguyen L, Seeber N, Schneider S, Herberger K
LASER MED SCI. 2023;38(1):110.

Prognostic value of von Willebrand factor levels in patients with metastatic melanoma treated by immune checkpoint inhibitors
Stadler J, Keller L, Mess C, Bauer A, Koett J, Geidel G, Heidrich I, Vidal-Y-Sy S, Andreas A, Stramaglia C, Sementsov M, Haberstroh W, Deitert B, Hoehne I, Reschke R, Haalck T, Pantel K, Gebhardt C, Schneider S
J IMMUNOTHER CANCER. 2023;11(5):.

Localized monkeypox infestation in MSM on pre-exposure prophylaxis
Torster L, Tegtmeyer J, Kött J, Christolouka M, Schneider S
J EUR ACAD DERMATOL. 2023;37(3):e366-e367.

Patient-reported treatment outcomes and safety of direct-to-consumer teledermatology for finasteride treatment in male androgenetic alopecia: A cross-sectional study
von Büren J, Hansen I, Kött J, Schröder F, Veneroso J, Schneider S, Abeck F
DIGIT HEALTH. 2023;9:20552076231205740.

Crosstalk between Circulating Tumor Cells and Plasma Proteins-Impact on Coagulation and Anticoagulation
Wang Y, Schneider S, Gorzelanny C
CANCERS. 2023;15(11):.

Unsachgemäße Systemtherapie bei schwerer atopischer Dermatitis – fatale Langzeitschäden
Abeck F, Booken N, Schneider S
HAUTARZT. 2022;73(8):638-640.

Telemedical care of men with androgenetic alopecia demonstrates improved access to care and patient benefit
Abeck F, Kött J, Wiesenhütter I, Hiebenthal T, Hansen I, Schneider S, von Büren J
J EUR ACAD DERMATOL. 2022;36(12):e1018-e1020.

Propylthiouracil-induced ANCA-associated vasculopathy
Alotaibi A, Alsubaie M, Burmeister A, Menz A, Schneider S
J DTSCH DERMATOL GES. 2022;20(2):223-226.

Activated Eosinophils Predict Longer Progression-Free Survival under Immune Checkpoint Inhibition in Melanoma
Ammann N, Schwietzer Y, Mess C, Stadler J, Geidel G, Kött J, Pantel K, Schneider S, Utikal J, Bauer A, Gebhardt C
CANCERS. 2022;14(22):.

Interplay between coagulation and inflammation in cancer: Limitations and therapeutic opportunities
Bauer A, Gorzelanny C, Gebhardt C, Pantel K, Schneider S
CANCER TREAT REV. 2022;102:.

Mucha-Habermann disease: a pediatric case report and proposal of a risk score
Blohm M, Ebenebe C, Rau C, Escherich C, Johannsen J, Escherich G, Driemeyer J, Nagel P, Kobbe R, Lütgehetmann M, Lennartz M, Booken N, Schneider S, Singer D
INT J DERMATOL. 2022;61(4):401-409.

Immunothrombotic Mechanisms Induced by Ingenol Mebutate Lead to Rapid Necrosis and Clearance of Anogenital Warts
Braun S, Bauer A, Németh C, Rózsa A, Rusch L, Erpenbeck L, Schloer S, Silling S, Metze D, Gerber P, Schneider S, Gyulai R, Homey B
INT J MOL SCI. 2022;23(21):.

Livedoid vasculopathy - A diagnostic and therapeutic challenge
Burg M, Mitschang C, Goerge T, Schneider S
FRONT MED-LAUSANNE. 2022;9:.

Imitation eines Hodgkin-Lymphoms durch Frühmanifestation einer Methotrexat-assoziierten lymphoproliferativen Erkrankung
Burg M, Schneider S
HAUTARZT. 2022;73(1):71-74.

Impact of neutrophil extracellular traps on fluid properties, blood flow and complement activation
Burmeister A, Vidal-Y-Sy S, Liu X, Mess C, Wang Y, Konwar S, Tschongov T, Häffner K, Huck V, Schneider S, Gorzelanny C
FRONT IMMUNOL. 2022;13:.

Emerging precision diagnostics in advanced cutaneous squamous cell carcinoma
Geidel G, Heidrich I, Kött J, Schneider S, Pantel K, Gebhardt C
NPJ PRECIS ONCOL. 2022;6(1):.

Value of cemiplimab in progressive metastatic cutaneous squamous cell carcinoma after kidney transplantation: a case report
Geidel G, Rünger A, Schneider S, Gebhardt C
J EUR ACAD DERMATOL. 2022;36(S1):49-52.

Cutaneous Angiosarcomas: Molecular Pathogenesis Guides Novel Therapeutic Approaches
Goerdt L, Schneider S, Booken N
J DTSCH DERMATOL GES. 2022;20(4):429-443.

Kutane Angiosarkome: molekulare Pathogenese und neue therapeutische Ansätze
Goerdt L, Schneider S, Booken N
J DTSCH DERMATOL GES. 2022;20(4):429-444.

Acute Generalized Exanthematous Pustulosis
Hansen I, Booken N, Schneider S
DTSCH ARZTEBL INT. 2022;119(50):878.

Ungewöhnliche Lokalisation einer klassischen Dermatose
Hansen I, Kött J, Booken N, Schneider S
DERMATOLOGIE. 2022;73(11):901-903.

Gain-of-function variant p.Pro2555Arg of von Willebrand factor increases aggregate size through altering stem dynamics
Huck V, Chen P, Xu E, Tischer A, Klemm U, Aponte-Santamaría C, Mess C, Obser T, Kutzki F, König G, Denis C, Gräter F, Wilmanns M, Auton M, Schneider S, Schneppenheim R, Hennig J, Brehm M
THROMB HAEMOSTASIS. 2022;122(2):226-239.

Vergleich dreier kommerzieller Kryomedien bezüglich des Einflusses auf die diagnostischen Spermienparameter
Kruschel E, Kopylow K, Laubis K, Hahn G, Steinert S, Salzbrunn A, Schneider S
J Reprodmed Endokrinol. 2022;2022(19 (Supplementum 3)):7.

Neutrophils activated by membrane attack complexes increase the permeability of melanoma blood vessels
Liu X, Wang Y, Bauer A, Kirschfink M, Ding P, Gebhardt C, Borsig L, Tüting T, Renné T, Häffner K, Hu W, Schneider S, Gorzelanny C
P NATL ACAD SCI USA. 2022;119(33):.

Persistent SOMAtic symptoms ACROSS diseases - from risk factors to modification: scientific framework and overarching protocol of the interdisciplinary SOMACROSS research unit (RU 5211)
Löwe B, Andresen V, Van den Bergh O, Huber T, von dem Knesebeck O, Lohse A, Nestoriuc Y, Schneider G, Schneider S, Schramm C, Ständer S, Vettorazzi E, Zapf A, Shedden-Mora M, Toussaint A
BMJ OPEN. 2022;12(1):.

Radiofrequency Microneedling for Skin Tightening of the Lower Face, Jawline, and Neck Region
Nguyen L, Blessmann M, Schneider S, Herberger K
DERMATOL SURG. 2022;48(12):1299-1305.

In vivo visualisation of tattoo particles using multiphoton tomography and fluorescence lifetime imaging
Nguyen L, Mess C, Schneider S, Huck V, Herberger K
EXP DERMATOL. 2022;31(11):1712-1719.

Incidence of pulmonary embolism and impact on mortality in patients with malignant melanoma
Rennebaum S, Schneider S, Henzler T, Desch A, Weiß C, Haubenreisser H, Goerdt S, Morelli J, Utikal J, Schoenberg S, Riffel J
CLIN IMAG. 2022;83:72-76.

Biological and psychosocial factors associated with the persistence of pruritus symptoms: protocol for a prospective, exploratory observational study in Germany (individual project of the Interdisciplinary SOMACROSS Research Unit [RU 5211])
Schneider G, Ständer S, Kahnert S, Pereira M, Mess C, Huck V, Agelopoulos K, Frank G, Schneider S
BMJ OPEN. 2022;12(7):.

Heparan sulfate dependent binding of plasmatic von Willebrand factor to blood circulating melanoma cells attenuates metastasis
Wang Y, Liu X, Obser T, Bauer A, Heyes M, Starzonek S, Zulal M, Opitz K, Ott L, Riethdorf S, Lange T, Pantel K, Bendas G, Schneider S, Kusche-Gullberg M, Gorzelanny C
MATRIX BIOL. 2022;111:76-94.

Vergleich von 3 Organkulturbedingungen für adultes Hodengewebe hinsichtlich Stimulation der Testosteronproduktion, Zellerhalt und IL-6-Sekretion
Aden N, Salzbrunn A, Schneider S, Kopylow K
J Reprodmed Endokrinol. 2021;18(5):249.

Adjuvante Pembrolizumab-assoziierte Hyperprogression eines Melanoms im Stadium III
Ammann N, Geidel G, Schneider S, Gebhardt C
J DTSCH DERMATOL GES. 2021;19(9):1341-1345.

Adjuvant pembrolizumab-related hyperprogression in stage III melanoma
Ammann N, Geidel G, Schneider S, Gebhardt C
J DTSCH DERMATOL GES. 2021;19(9):1341-1345.

Monocyte activation and acquired autoimmune protein S deficiency promote disseminated intravascular coagulation in a patient with primary antiphospholipid syndrome
Beckmann L, Voigtländer M, Holstein K, Lennartz M, Schneider S, Haddad M, Renné T, Bokemeyer C, Rolling C, Langer F
RES PRACT THROMB HAE. 2021;5(5):.

Immunoglobulin M pemphigoid
Boch K, Hammers C, Goletz S, Kamaguchi M, Ludwig R, Schneider S, Zillikens D, Hadaschik E, Schmidt E
J AM ACAD DERMATOL. 2021;85(6):1486-1492.

Pathogenic Activation and Therapeutic Blockage of FcαR-Expressing Polymorphonuclear Leukocytes in IgA Pemphigus
Emtenani S, Ghorbanalipoor S, Mayer-Hain S, Kridin K, Komorowski L, Probst C, Hashimoto T, Pas H, Męcińska-Jundziłł K, Czajkowski R, Recke A, Sunderkötter C, Schneider S, Hundt J, Zillikens D, Schmidt E, Ludwig R, Hammers C
J INVEST DERMATOL. 2021;141(12):2820-2828.

Local blood coagulation drives cancer cell arrest and brain metastasis in a mouse model
Feinauer M, Schneider S, Berghoff A, Robador J, Tehranian C, Karreman M, Venkataramani V, Solecki G, Grosch J, Gunkel K, Kovalchuk B, Mayer F, Fischer M, Breckwoldt M, Brune M, Schwab Y, Wick W, Bauer A, Winkler F
BLOOD. 2021;137(9):1219-1232.

Hyperprogression fortgeschrittener Melanomerkrankung unter Pembrolizumab adjuvant
Geidel G, Ammann N, Schneider S, Gebhardt C
J DTSCH DERMATOL GES. 2021;19(S1):37-39.

Früherkennung von psychischer Komorbidität in der stationären dermatologischen und internistischen Versorgung: Darstellung eines neuen Versorgungskonzeptes
Kohlmann S, Köster F, Braunschneider L, Meier A, Lohse A, Schneider S, Loeper S, Löwe B
PSYCHOTHER PSYCH MED. 2021;71(9-10):406-411.

Screening auf psychische Komorbiditäten in der Dermatologie: Erfolgreiche Implementierung eines Screenings auf psychische Komorbiditäten im Bereich der stationären dermatologischen Versorgung
Köster F, Kohlmann S, Loeper S, Löwe B, Schneider S
HAUTARZT. 2021;72(3):244-248.

CD74 and CD44 Expression on CTCs in Cancer Patients with Brain Metastasis
Loreth D, Schuette M, Zinke J, Mohme M, Piffko A, Schneegans S, Stadler J, Janning M, Loges S, Joosse S, Lamszus K, Westphal M, Müller V, Glatzel M, Matschke J, Gebhardt C, Schneider S, Belczacka I, Volkmer B, Greinert R, Yaspo M, Harter P, Pantel K, Wikman H
INT J MOL SCI. 2021;22(13):.

Melanoma Associated Chitinase 3-Like 1 Promoted Endothelial Cell Activation and Immune Cell Recruitment
Ramos-Espinosa G, Wang Y, Brandner J, Schneider S, Gorzelanny C
INT J MOL SCI. 2021;22(8):.

Involvement of platelet-derived VWF in metastatic growth of melanoma in the brain
Robador J, Feinauer M, Schneider S, Mayer F, Gorzelanny C, Sacharow A, Liu X, Berghoff A, Brehm M, Hirsch D, Stadler J, Vidal-Y-Si S, Wladykowski E, Asong M, Nowak K, Seiz-Rosenhagen M, Umansky V, Mess C, Pantel K, Winkler F, Bauer A
NEURO-ONCOL ADV. 2021;3(1):.

Ein interessanter Fall: Rezidivierendes Ulcus zentrofazial
Schreiner S, Alotaibi A, Menz A, Siemann-Harms U, Booken N, Schneider S
J DTSCH DERMATOL GES. 2021;19(S1):5-7.

Incidence of pemphigoid diseases in Northern Germany in 2016 - first data from the Schleswig-Holstein Registry of Autoimmune Bullous Diseases
van Beek N, Weidinger A, Schneider S, Kleinheinz A, Gläser R, Holtsche M, von Georg A, Hammers C, Hübner F, Lima A, Gola D, Sadik C, Zillikens D, Katalinic A, Schmidt E, König I
J EUR ACAD DERMATOL. 2021;35(5):1197-1202.

Platelet endothelial cell adhesion molecule-1 is a gatekeeper of neutrophil transendothelial migration in ischemic stroke
Winneberger J, Schöls S, Lessmann K, Rández-Garbayo J, Bauer A, Mohamud Yusuf A, Hermann D, Gunzer M, Schneider S, Fiehler J, Gerloff C, Gelderblom M, Ludewig P, Magnus T
BRAIN BEHAV IMMUN. 2021;93:277-287.

Claudin-1 decrease impacts epidermal barrier function in atopic dermatitis lesions dose-dependently
Bergmann S, von Buenau B, Vidal-Y-Sy S, Haftek M, Wladykowski E, Houdek P, Lezius S, Duplan H, Bäsler K, Dähnhardt-Pfeiffer S, Gorzelanny C, Schneider S, Rodriguez E, Stölzl D, Weidinger S, Brandner J
SCI REP-UK. 2020;10(1):2024.

Skin Barriers in Dermal Drug Delivery: Which Barriers Have to Be Overcome and How Can We Measure Them?
Gorzelanny C, Mess C, Schneider S, Huck V, Brandner J
PHARMACEUTICS. 2020;12(7):.

Painful erythema of the scrotum
Hartjen A, Booken N, Schneider S
J DTSCH DERMATOL GES. 2020;18(9):1059-1061.

Schmerzhafte Rötung am Skrotum
Hartjen A, Booken N, Schneider S
J DTSCH DERMATOL GES. 2020;18(9):1059-1061.

No link between male infertility and HEV genotype 3 infection
Horvatits T, Varwig-Janssen D, Schulze Zur Wiesch J, Lübke R, Reucher S, Frerk S, Addo M, Schneider S, Lohse A, Luetgehetmann M, Pischke S
GUT. 2020;69(6):1150-1151.

Bladder cancer-derived interleukin-1 converts the vascular endothelium into a pro-inflammatory and pro-coagulatory surface
John A, Günes C, Bolenz C, Vidal-Y-Sy S, Bauer A, Schneider S, Gorzelanny C
BMC CANCER. 2020;20(1):1178.

Urothelial Carcinoma of the Bladder Induces Endothelial Cell Activation and Hypercoagulation
John A, Robador J, Vidal-Y-Sy S, Houdek P, Wladykowski E, Günes C, Bolenz C, Schneider S, Bauer A, Gorzelanny C
MOL CANCER RES. 2020;18(7):1099-1109.

Upshaw-Schulman syndrome-associated ADAMTS13 variants possess proteolytic activity at the surface of endothelial cells and in simulated circulation
Letzer A, Lehmann K, Mess C, König G, Obser T, Peine S, Schneppenheim S, Budde U, Schneider S, Schneppenheim R, Brehm M
PLOS ONE. 2020;15(5):e0232637.

ALCAM contributes to brain metastasis formation in non-small-cell lung cancer through interaction with the vascular endothelium
Münsterberg J, Loreth D, Brylka L, Werner S, Karbanova J, Gandrass M, Schneegans S, Besler K, Hamester F, Robador J, Bauer A, Werner Schneider S, Wrage M, Lamszus K, Matschke J, Vashist Y, Uzunoglu G, Steurer S, Horst A, Oliveira-Ferrer L, Glatzel M, Schinke T, Corbeil D, Pantel K, Maire C, Wikman H
NEURO-ONCOLOGY. 2020;22(7):955-966.

DNA binds to a specific site of the adhesive blood-protein von Willebrand factor guided by electrostatic interactions
Sandoval-Pérez A, Berger R, Garaizar A, Farr S, Brehm M, König G, Schneider S, Collepardo-Guevara R, Huck V, Rädler J, Aponte-Santamaría C
NUCLEIC ACIDS RES. 2020;48(13):7333-7344.

Pre-analytical factors affecting the establishment of a single tube assay for multiparameter liquid biopsy detection in melanoma patients
Schneegans S, Lück L, Besler K, Bluhm L, Stadler J, Staub J, Greinert R, Volkmer B, Kubista M, Gebhardt C, Sartori A, Irwin D, Serkkola E, Af Hällström T, Lianidou E, Sprenger-Haussels M, Hussong M, Mohr P, Schneider S, Shaffer J, Pantel K, Wikman H
MOL ONCOL. 2020;14(5):1001-1015.

Platelet adhesion and aggregate formation controlled by immobilised and soluble VWF
Schneider M, Fallah M, Mess C, Obser T, Schneppenheim R, Alexander-Katz A, Schneider S, Huck V
BMC MOL CELL BIOL. 2020;21(1):64.

Plombage rupture presenting as a subcutaneous tumor: Unexpected differential diagnosis
Siemann-Harms U, Alotaibi A, Schneider S
JAAD case reports. 2020;6(4):282-284.

Differences of the tumour cell glycocalyx affect binding of capsaicin-loaded chitosan nanocapsules
von Palubitzki L, Wang Y, Hoffmann S, Vidal-Y-Sy S, Zobiak B, Failla A, Schmage P, John A, Osorio-Madrazo A, Bauer A, Schneider S, Goycoolea F, Gorzelanny C
SCI REP-UK. 2020;10(1):22443.

Eosinophilic Granulomatosis with Polyangiitis Manifesting as Recurrent Nasal Polyps and Hemorrhagic Necrotic Bullae: A Rare Disease Successfully Treated with Azathioprine
Alotaibi A, Schneider S
Case Rep Dermatol. 2019;11(1):28-35.

42/m mit derben erythematösen Knoten im Bereich der Leiste: Vorbereitung auf die Facharztprüfung: Folge 46
Booken N, Menz A, Schneider S
HAUTARZT. 2019;70(Suppl 1):75-77.

Intra-Patient Heterogeneity of Circulating Tumor Cells and Circulating Tumor DNA in Blood of Melanoma Patients
Gorges K, Wiltfang L, Gorges T, Sartori A, Hildebrandt L, Keller L, Volkmer B, Peine S, Babayan A, Moll I, Schneider S, Twarock S, Mohr P, Fischer J, Pantel K
CANCERS. 2019;11(11):1685.

Platelets in Skin Autoimmune Diseases
Liu X, Gorzelanny C, Schneider S
FRONT IMMUNOL. 2019;10:1453.

CCL2 is a vascular permeability factor inducing CCR2-dependent endothelial retraction during lung metastasis
Roblek M, Protsyuk D, Becker P, Stefanescu C, Gorzelanny C, Glaus Garzon J, Knopfova L, Heikenwalder M, Luckow B, Schneider S, Borsig L
MOL CANCER RES. 2019;17(3):783-793.

The von Willebrand factor Tyr2561 allele is a gain-of-function variant and a risk factor for early myocardial infarction
Schneppenheim R, Hellermann N, Brehm M, Klemm U, Obser T, Huck V, Schneider S, Denis C, Tischer A, Auton M, März W, Xu E, Wilmanns M, Zotz R
BLOOD. 2019;133(4):356-365.

Ein interessanter Fall: Die Erworbene Hemmkörper-Hämophilie
Schreiner S, Siemann-Harms U, Booken N, Schneider S
J DTSCH DERMATOL GES. 2019;17 Suppl 2:25-27.

Characteristics, risk factors and treatment reality in livedoid vasculopathy - a multicentre analysis
Weishaupt C, Strölin A, Kahle B, Kreuter A, Schneider S, Gerss J, Eveslage M, Drabik A, Goerge T
J EUR ACAD DERMATOL. 2019;33(9):1784-1791.

Decreased Invasion of Urothelial Carcinoma of the Bladder by Inhibition of Matrix-Metalloproteinase 7
Bolenz C, Knauf D, John A, Erben P, Steidler A, Schneider S, Günes C, Gorzelanny C
Bladder Cancer. 2018;4(1):67-75.

The endothelial glycocalyx anchors von Willebrand factor fibers to the vascular endothelium
Kalagara T, Moutsis T, Yang Y, Pappelbaum K, Farken A, Cladder-Micus L, Vidal-Y-Sy S, John A, Bauer A, Moerschbacher B, Schneider S, Gorzelanny C
BLOOD ADV. 2018;2(18):2347-2357.

Cellular stress induces erythrocyte assembly on intravascular von Willebrand factor strings and promotes microangiopathy
Nicolay J, Thorn V, Daniel C, Amann K, Siraskar B, Lang F, Hillgruber C, Goerge T, Hoffmann S, Gorzelanny C, Huck V, Mess C, Obser T, Schneppenheim R, Fleming I, Schneider M, Schneider S
SCI REP-UK. 2018;8(1):10945.

Jedes Kind braucht einen Namen
Schneider S
J DTSCH DERMATOL GES. 2018;16(12):1410-1411.

Increased Prevalence of Filaggrin Deficiency in 51 Patients with Recessive X-Linked Ichthyosis Presenting for Dermatological Examination
Süßmuth K, Gruber R, Rodriguez E, Traupe H, Amler S, Sánchez-Guijo A, Valentin F, Tarinski T, Straub N, Metze D, Schneider S, Hausser I, Baurecht H, Weidinger S, Oji V
J INVEST DERMATOL. 2018;138(3):709-711.

Tight Junction barriers in human hair follicles - role of claudin-1
Zorn-Kruppa M, Vidal-Y-Sy S, Houdek P, Wladykowski E, Grzybowski S, Gruber R, Gorzelanny C, Harcup J, Schneider S, Majumdar A, Brandner J
SCI REP-UK. 2018;8:12800.

Klinische Merkmale und Versorgung von Hautkrebs. Gezielte Behandlung
Augustin M, Schneider S
Ärzteblatt Mecklenburg-Vorpommern. 2017;27(5):165-171.

Klinische Merkmale und Versorgung von Hautkrebs. Gezielte Behandlung
Augustin M, Schneider S
Hamb Ärztebl. 2017;71(3):12-16.

Biphasic influence of Staphylococcus aureus on human epidermal tight junctions
Bäsler K, Galliano M, Bergmann S, Rohde H, Wladykowski E, Vidal-Y-Sy S, Guiraud B, Houdek P, Schüring G, Volksdorf T, Caruana A, Bessou-Touya S, Schneider S, Duplan H, Brandner J
ANN NY ACAD SCI. 2017;1405(1):53-70.

D-dimers in malignant melanoma: Association with prognosis and dynamic variation in disease progress
Desch A, Gebhardt C, Utikal J, Schneider S
INT J CANCER. 2017;140(4):914-921.

Role of the Coagulation System in Genitourinary Cancers: Review
John A, Gorzelanny C, Bauer A, Schneider S, Bolenz C
CLIN GENITOURIN CANC. 2017.

Treating onychomycosis with the short-pulsed 1064-nm-Nd:YAG laser: results of a prospective randomized controlled trial
Karsai S, Jäger M, Oesterhelt A, Weiss C, Schneider S, Jünger M, Raulin C
J EUR ACAD DERMATOL. 2017;31(1):175-180.

Rezidivierende Abszesse - oder doch mehr?
Kirsten N, Schneider S, Augustin M
Hamb Ärztebl. 2017;71(10):30-31.

From morphology to clinical pathophysiology: multiphoton fluorescence lifetime imaging at patients' bedside
Meß C, Zens K, Gorzelanny C, Metze D, Luger T, König K, Schneider S, Huck V
Proc. SPIE. 2017;10069:100691E-100691E.

Margination and stretching of von Willebrand factor in the blood stream enable adhesion
Rack K, Huck V, Hoore M, Fedosov D, Schneider S, Gompper G
SCI REP-UK. 2017;7(1):14278.

Surgical procedures in patients with haemophilic arthropathy of the ankle
Barg A, Morris S, Schneider S, Phisitkul P, Saltzman C
HAEMOPHILIA. 2016;22(3):e156-76.

Leda-1/Pianp is targeted to the basolateral plasma membrane by a distinct intracellular juxtamembrane region and modulates barrier properties and E-Cadherin processing
Evdokimov K, Biswas S, Schledzewski K, Winkler M, Gorzelanny C, Schneider S, Goerdt S, Géraud C
BIOCHEM BIOPH RES CO. 2016;475(4):342-9.

Heparins that block VEGF-A-mediated von Willebrand factor fiber generation are potent inhibitors of hematogenous but not lymphatic metastasis
Goertz L, Schneider S, Desch A, Mayer F, Koett J, Nowak K, Karampinis I, Bohlmann M, Umansky V, Bauer A
ONCOTARGET. 2016;7(42):68527-68545.

Silver nanoparticle-enriched diamond-like carbon implant modification as a mammalian cell compatible surface with antimicrobial properties
Gorzelanny C, Kmeth R, Obermeier A, Bauer A, Halter N, Kümpel K, Schneider M, Wixforth A, Gollwitzer H, Burgkart R, Stritzker B, Schneider S
SCI REP-UK. 2016;6:22849.

Monocyte Induction of E-Selectin-Mediated Endothelial Activation Releases VE-Cadherin Junctions to Promote Tumor Cell Extravasation in the Metastasis Cascade
Häuselmann I, Roblek M, Protsyuk D, Huck V, Knopfova L, Grässle S, Bauer A, Schneider S, Borsig L
CANCER RES. 2016;76(18):5302-12.

From morphology to biochemical state - intravital multiphoton fluorescence lifetime imaging of inflamed human skin
Huck V, Gorzelanny C, Thomas K, Getova V, Niemeyer V, Zens K, Unnerstall T, Feger J, Fallah M, Metze D, Ständer S, Luger T, Koenig K, Mess C, Schneider S
SCI REP-UK. 2016;6:22789.

Hybrid electrospun chitosan-phospholipids nanofibers for transdermal drug delivery
Mendes A, Gorzelanny C, Halter N, Schneider S, Chronakis I
INT J PHARMACEUT. 2016;510(1):48-56.

Nucleoside diphosphate kinase B deficiency causes a diabetes-like vascular pathology via up-regulation of endothelial angiopoietin-2 in the retina
Qiu Y, Zhao D, Butenschön V, Bauer A, Schneider S, Skolnik E, Hammes H, Wieland T, Feng Y
ACTA DIABETOL. 2016;53(1):81-9.

Association of Cole disease with novel heterozygous mutations in the somatomedin-B domains of the ENPP1 gene: necessary, but not always sufficient
Schlipf N, Traupe H, Gilaberte Y, Peitsch W, Hausser I, Oji V, Schmieder A, Schneider S, Demmer P, Rösler B, Fischer J
BRIT J DERMATOL. 2016;174(5):1152-6.

Anticoagulation with rivaroxaban for livedoid vasculopathy (RILIVA), a multicentre, single-arm, open-label, phase 2a, proof-of-concept trial
Weishaupt C, Strölin A, Kahle B, Kreuter A, Schneider S, Gerss J, Eveslage M, Drabik A, Goerge T
LANCET HAEMATOL. 2016;3(2):e72-9.

Force-sensitive autoinhibition of the von Willebrand factor is mediated by interdomain interactions
Aponte-Santamaria C, Huck V, Posch S, Bronowska A, Grässle S, Brehm M, Obser T, Schneppenheim R, Hinterdorfer P, Schneider S, Baldauf C, Grater F
BIOPHYS J. 2015;108(9):2312-21.

von Willebrand factor fibers promote cancer-associated platelet aggregation in malignant melanoma of mice and humans
Bauer A, Suckau J, Frank K, Desch A, Goertz L, Wagner A, Hecker M, Goerge T, Umansky L, Beckhove P, Utikal J, Gorzelanny C, Diaz-Valdes N, Umansky V, Schneider S
BLOOD. 2015;125(20):3153-63.

Monitoring wound healing by multiphoton tomography/endoscopy
König K, Weinigel M, Bückle R, Kaatz M, Hipler C, Zens K, Schneider S, Huck V
Proc. SPIE. 2015;9303:93030F-93030F-6.

Mechanism and functional impact of CD40 ligand-induced von Willebrand factor release from endothelial cells
Möller K, Adolph O, Grunow J, Elrod J, Popa M, Ghosh S, Schwarz M, Schwale C, Grässle S, Huck V, Bruehl C, Wieland T, Schneider S, Nobiling R, Wagner A, Hecker M
THROMB HAEMOSTASIS. 2015;113(5):1095-108.

Acid citrate dextrose extracorporeal photopheresis is an alternative treatment option for patients with heparin allergy
Stadler S, Booken N, Schneider S, Goerdt S, Klemke C, Utikal J
INT J DERMATOL. 2015;54(7):e266-7.

Nuclear heparanase-1 activity suppresses melanoma progression via its DNA-binding affinity
Yang Y, Gorzelanny C, Bauer A, Halter N, Komljenovic D, Bäuerle T, Borsig L, Roblek M, Schneider S
ONCOGENE. 2015;34(47):5832-42.

The various states of von Willebrand factor and their function in physiology and pathophysiology
Huck V, Schneider M, Gorzelanny C, Schneider S
THROMB HAEMOSTASIS. 2014;111(4):598-609.

Desmoglein 2 depletion leads to increased migration and upregulation of the chemoattractant secretoneurin in melanoma cells
Peitsch W, Doerflinger Y, Fischer-Colbrie R, Huck V, Bauer A, Utikal J, Goerdt S, Schneider S
PLOS ONE. 2014;9(2):e89491.

Early treatment with rutoside and ascorbic acid is highly effective for progressive pigmented purpuric dermatosis
Schober S, Peitsch W, Bonsmann G, Metze D, Thomas K, Goerge T, Luger T, Schneider S
J DTSCH DERMATOL GES. 2014;12(12):1112-9.

Melanoma-derived IL-1 converts vascular endothelium to a proinflammatory and procoagulatory phenotype via NFkappaB activation
Strozyk E, Desch A, Poeppelmann B, Magnolo N, Wegener J, Huck V, Schneider S
EXP DERMATOL. 2014;23(9):670-6.

Uptake kinetics and nanotoxicity of silica nanoparticles are cell type dependent
Blechinger J, Bauer A, Torrano A, Gorzelanny C, Bräuchle C, Schneider S
SMALL. 2013;9(23):3970-80, 3906.

Assessing the invasive potential of bladder cancer: development and validation of a new preclinical assay
Bolenz C, Gorzelanny C, Knauf D, Keil T, Steidler A, Halter N, Martini T, Schneider S
J UROLOGY. 2013;189(5):1939-44.

Blood-clotting-inspired reversible polymer-colloid composite assembly in flow
Chen H, Fallah M, Huck V, Angerer J, Reininger A, Schneider S, Schneider M, Alexander-Katz A
NAT COMMUN. 2013;4:1333.

Circulating but not immobilized N-deglycosylated von Willebrand factor increases platelet adhesion under flow conditions
Fallah M, Huck V, Niemeyer V, Desch A, Angerer J, McKinnon T, Wixforth A, Schneider S, Schneider M
BIOMICROFLUIDICS. 2013;7(4):44124.

Coculture model of sensory neurites and keratinocytes to investigate functional interaction: chemical stimulation and atomic force microscope-transmitted mechanical stimulation combined with live-cell imaging
Klusch A, Ponce L, Gorzelanny C, Schäfer I, Schneider S, Ringkamp M, Holloschi A, Schmelz M, Hafner M, Petersen M
J INVEST DERMATOL. 2013;133(5):1387-90.

Highly invasive melanoma cells activate the vascular endothelium via an MMP-2/integrin alphavbeta5-induced secretion of VEGF-A
Desch A, Strozyk E, Bauer A, Huck V, Niemeyer V, Wieland T, Schneider S
AM J PATHOL. 2012;181(2):693-705.

Development of a novel two-channel microfluidic system for biomedical applications in cancer research
Rajabi T, Huck V, Ahrens R, Apfel M, Kim S, Schneider S, Guber A
BIOMED ENG-BIOMED TE. 2012;57:921-922.

Cytotoxicity of silica nanoparticles through exocytosis of von Willebrand factor and necrotic cell death in primary human endothelial cells
Bauer A, Strozyk E, Gorzelanny C, Westerhausen C, Desch A, Schneider M, Schneider S
BIOMATERIALS. 2011;32(33):8385-93.

Intravital multiphoton tomography as an appropriate tool for non-invasive in vivo analysis of human skin affected with atopic dermatitis
Huck V, Gorzelanny C, Thomas K, Mess C, Dimitrova V, Schwarz M, Riemann I, Niemeyer V, Luger T, König K, Schneider S
Proc. SPIE. 2011;7883:78830R-78830R.

Human macrophage activation triggered by chitotriosidase-mediated chitin and chitosan degradation
Gorzelanny C, Pöppelmann B, Pappelbaum K, Moerschbacher B, Schneider S
BIOMATERIALS. 2010;31(33):8556-63.

5D-intravital tomography as a novel tool for non-invasive in-vivo analysis of human skin
König K, Weinigel M, Breunig H, Gregory A, Fischer P, Kellner-Höfer M, Bückle R, Schwarz M, Riemann I, Stracke F, Huck V, Gorzelanny C, Schneider S
Proc. SPIE. 2010;7555:75551I-75551I.

Microfluidic reveals generation of platelet-strings on tumor-activated endothelium
Goerge T, Kleineruschkamp F, Barg A, Schnaeker E, Huck V, Schneider M, Steinhoff M, Schneider S
THROMB HAEMOSTASIS. 2007;98(2):283-6.

Specific interaction between chitosan and matrix metalloprotease 2 decreases the invasive activity of human melanoma cells
Gorzelanny C, Pöppelmann B, Strozyk E, Moerschbacher B, Schneider S
BIOMACROMOLECULES. 2007;8(10):3035-40.

Delay of acute intracellular pH recovery after acidosis decreases endothelial cell activation
Huck V, Niemeyer A, Goerge T, Schnaeker E, Ossig R, Rogge P, Schneider M, Oberleithner H, Schneider S
J CELL PHYSIOL. 2007;211(2):399-409.

Shear-induced unfolding triggers adhesion of von Willebrand factor fibers
Schneider S, Nuschele S, Wixforth A, Gorzelanny C, Alexander-Katz A, Netz R, Schneider M
P NATL ACAD SCI USA. 2007;104(19):7899-903.

Atomic force microscopy as an innovative tool for nanoanalysis of native stratum corneum
Gorzelanny C, Goerge T, Schnaeker E, Thomas K, Luger T, Schneider S
EXP DERMATOL. 2006;15(5):387-91.

Letzte Aktualisierung aus dem FIS: 13.11.2024 - 23:34 Uhr